Showing 1871-1880 of 2050 results for "".
- Asymptomatic Spread of Coronavirus is ‘Very Rare,’ WHO Sayshttps://modernod.com/news/asymptomatic-spread-of-coronavirus-is-very-rare-who-says/2477878/Coronavirus patients without symptoms aren’t driving the spread of the virus, World Health Organization officials said Monday, casting doubt on concerns by some researchers that the disease could be difficult to contain due to asymptomatic infections, CNBC
- CMS Increases Penalties Following Nearly 26K COVID-19 Nursing Home Deathshttps://modernod.com/news/cms-increases-penalties-following-nearly-26k-covid-19-nursing-home-deaths/2477852/The Trump administration has increased enforcement of states and nursing homes that have been repeat offenders for not following infection control practices, according to a FierceHealthcare
- Can You Catch COVID-19 Through Your Eyes?https://modernod.com/news/can-you-catch-covid-19-through-your-eyes/2477840/You can catch COVID-19 if an infected person coughs or sneezes and contagious droplets enter your nose or mouth. But can you become ill if the virus lands in your eyes? Virologist Joseph Fair, PhD, an NBC News contributor, raised that concern when he became critically ill with COVID-19, ac
- Adverum Biotechnologies Announces New INFINITY Phase 2 Trial for DME Drug Candidatehttps://modernod.com/news/adverum-biotechnologies-announces-new-infinity-phase-2-trial-for-dme-drug-candidate/2477842/Adverum Biotechnologies announced the initiation of INFINITY, a phase 2, multicenter, randomized, double-masked, active comparator-controlled trial to assess a single intravitreal (IVT) injection of ADVM-022 in patients with diabetic macular edema (DME). The company also reported financial resul
- Port Delivery System With Ranibizumab Shows Positive Phase 3 Results in Wet AMDhttps://modernod.com/news/port-delivery-system-with-ranibizumab-shows-positive-phase-3-results-in-wet-amd/2477824/Genentech announced positive topline results from the phase 3 Archway study, evaluating Port Delivery System with ranibizumab (PDS) in people living with wet age-related macular degeneration (AMD). PDS is a permanent refillable eye implant, approximately the size of a grain of rice, which continu
- Scientists Warn CDC Testing Data Could Create Misleading Picture Of Pandemichttps://modernod.com/news/scientists-warn-cdc-testing-data-could-create-misleading-picture-of-pandemic/2477814/The Centers for Disease Control and Prevention has acknowledged that it is mixing the results of two different kinds of tests in the agency’s tally of testing for the coronavirus, raising concerns among some scientists that it
- Reopen Eyecare Website Launches Todayhttps://modernod.com/news/reopen-eyecare-website-launches-today/2477805/Reopeneyecare.com, a new digital platform designed to help eyecare providers navigate the implications of the COVID-19 pandemic on their businesses, launched today. Featuring content specially curated by a taskforce of vision community leaders and sponsored by The Vision Council, the website is i
- Market Scope: Premium IOLs Expected to Drive Market Growth Over the Next 5 Yearshttps://modernod.com/news/market-scope-premium-iols-expected-to-drive-market-growth-over-the-next-5-years/2477796/The revenue contribution of premium IOLs is expected to grow over the next 5 years as the number and different types of IOL designs offered to cataract and refractive patients seeking better visual outcomes increases, according to a Market Scope report. In 2019, premium IOLs accounted a th
- Atia Vision Closes Second Tranche Of $20M In Series D Financinghttps://modernod.com/news/atia-vision-closes-second-tranche-of-20m-in-series-d-financing/2477793/Atia Vision, which is developing of a modular presbyopia-correcting accommodating IOL, announced the closing of its second tranche of a Series D $20M financing. The financing will be used to continue early clinical experience treating cataract patients and support ex
- Kubota Vision Introduces Electronic Eyeglasses to Stop Myopia in Childrenhttps://modernod.com/news/kubota-vision-introduces-electronic-eyeglasses-to-stop-myopia-in-children/2477794/Kubota Vision announced positive clinical results from myopia control tests in humans. Utilizing electronic tabletop optical projection devices that embody Kubota Glasses technology, myopically-defocused images were projected on the peripheral retina of subjects to study if progression of myopia